Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

6 Months Ended

May 31, 2019

Variables used to determine the fair value of the options granted for the three and six months ended May 31, 2019 and May 31, 2018, respectively, are as follows:

	Three Months Ended			Three Months Ended			Six Months Ended			Six Months Ended
	May 31, 2019			May 31, 2018			May 31, 2019			May 31, 2018
Weighted average values:
Expected dividends		0	%		0	%		0	%		0	%
Expected volatility		51.2	%		50.8	%		51.2	%		50.8	%
Risk free interest rate		2.31	%		2.67	%		2.31	%		2.67	%
Expected life		5 years			5 years			5 years			5 years

Service-Based Vesting Condition Options [Member]

Stock Option Activity

Stock option activity for options with only service-based vesting conditions for the six months ended May 31, 2019, was as follows:

				Weighted		Weighted Average
				Average		Remaining		Aggregate
	Options			Exercise Price		Contractual Life (Years)		Intrinsic Value
Outstanding at November 30, 2018		1,001,365		$	2.77		3.97	$	4,580,967
Granted		1,500			7.04				990
Exercised		(2,500	)		2.28				14,175
Expired/forfeited		(7,500	)		2.22				41,075
Outstanding at May 31, 2019		992,865		$	2.79		3.57	$	4,889,909
Exercisable at May 31, 2019		969,821		$	2.69		3.55	$	4,868,182

Significant Option Groups Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at May 31, 2019 and related price and contractual life information are as follows:

	Outstanding						Exercisable
			Weighted
			Average		Weighted				Weighted
Range of Exercise Prices	Outstanding		Remaining Contractual Life (Years)		Average Exercise Price		Outstanding		Average Exercise Price
$ 1.01 to $2.00		422,500		2.44	$	1.73		422,500	$	1.73
$2.01 to $3.00		265,000		2.13	$	2.72		265,000	$	2.72
$3.01 to $4.00		227,229		6.67	$	3.18		223,062	$	3.18
$6.01 to $7.00		25,000		7.84	$	6.95		23,334	$	6.98
$7.01 to $8.00		53,136		4.59	$	7.83		35,925	$	7.82
		992,865		3.57	$	2.79		969,821	$	2.69

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of May 31, 2019, and changes during the six months ended May 31, 2019, is presented below:


				Weighted Average
				Grant-Date
	Options			Fair Value
Non-vested at November 30, 2018		40,254		$	3.06
Granted		1,500			3.28
Vested		(18,710	)		3.23
Forfeited		—			—
Non-vested at May 31, 2019		23,044		$	2.94